Tag: CKD

Latest News

Empagliflozin reduces CKD progression in type 2 diabetics with cardiovascular disease

Newsemia
Empagliflozin (EMPA), a selective inhibitor of sodium/glucose cotransporter 2 (SGLT2 inhibitors, “gliflozines”), reduces CKD progression in type 2 diabetics (T2D) with cardiovascular disease, presumably by...
Latest News

COVID-19 Daily: Debate Over Vitamin D, Dogs Sniff Out COVID

Newsemia
These are the coronavirus stories you need to know about today. Source link...
Latest News

Advice for Managing Acute Kidney Injury in COVID-19 Patients

Newsemia
Nephrologist Anitha Vijayan recently discussed the practical aspects of renal replacement therapy in patients with AKI and COVID-19 for ASN. Medscape asked her to share...
Latest News

COVID-19 and Angiotensin Drugs: Help or Harm?

Newsemia
The controversy about whether ACE inhibitors and angiotensin blockers may affect COVID-19 infection continues, with hypotheses suggesting these drugs may both help or harm the...
Neurology

COVID-19 and Angiotensin Drugs: Help or Harm?

Newsemia
The controversy about whether ACE inhibitors and angiotensin blockers may affect COVID-19 infection continues, with hypotheses suggesting these drugs may both help or harm the...
Neurology

ADA Advises Wider Use of Newer Glucose-Lowering Drugs

Newsemia
In the 2020 Standards of Care, the American Diabetes Association advises consideration of SGLT2 inhibitors and GLP-1 receptor agonists in patients with high CVD or...
Latest News

Researchers move one step closer to understanding complex physiology of CKD patients

Newsemia
Researchers have further analyzed a known signaling pathway they believe brings them one step closer to understanding the complex physiology of patients with chronic kidney...
Neurology

ARBs Linked to Increased Suicide Risk, Experts Skeptical

Newsemia
A new study suggests an increased risk for suicide associated with angiotensin receptor blockers compared with ACE inhibitors among older adults, but leading cardiovascular experts...
Neurology

Adding Patiromer Allows More Spironolactone in Resistant HTN, CKD

Newsemia
With or without heart failure, add-on treatment with the potassium sequestrant ‘enabled’ more intensive use of the aldosterone blocker otherwise limited by hyperkalemia, according to...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World